Prime Therapeutics Communications
Prime Therapeutics produces a variety of communications to help keep you apprised of changes and anticipated events in the pharmaceuticals industry. These materials include drug alerts, drug profiles, therapeutic category profiles and pipeline updates.
On this page we will link you to the most current Prime Therapeutics communications which will be archived quarterly.
Third Quarter updates include:
- Prime Generic Update: Arimidex – July 2, 2010
- Prime Generic Update: Effexor XR – July 1, 2010
- Prime Drug Insights: June Pipeline Updates – July 1, 2010
Please remember that these communications are for informational purposes only and that benefit coverage varies.
Prime Therapeutics LLC is a pharmacy benefit management company. Blue Cross and Blue Shield of Texas contracts with Prime Therapeutics to provide pharmacy benefit management and other related services. Blue Cross and Blue Shield of Texas, as well as several other independent Blue Cross and Blue Shield Plans, has an ownership interest in Prime Therapeutics LLC.